ArticleHaematologica2025

Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

Sarah Bertoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.